These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28925360)

  • 1. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease.
    Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H
    Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
    Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
    Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
    Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
    Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
    Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
    Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
    Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
    Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease.
    Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
    Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
    Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of one control and one tumor-specific induced pluripotent stem cell line from laryngeal carcinoma patient.
    Zhang Y; Zhu J; Dai Y; Wang L; Liu R
    Stem Cell Res; 2017 Dec; 25():283-285. PubMed ID: 29246575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male.
    Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S
    Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
    Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
    Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
    Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.